Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
Sunitinib
×
30 days
×
Clear all
Filters
3
NCT02811861
2026-02-23
CLEAR
Eisai Inc.
Phase 3
Active not recruiting
1,069 enrolled
12 charts
1 FDA